Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion type Assertion NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_head.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion description "[Pharmacological or dominant-negative JNK inhibition restricts DLBCL survival in vitro and in vivo and synergizes strongly with the Bruton's tyrosine kinase inhibitor ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion evidence source_evidence_literature NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion SIO_000772 25847947 NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion wasDerivedFrom befree-2016 NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion wasGeneratedBy ECO_0000203 NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.